10/3
02:05 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/2
11:20 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
10/1
04:05 pm
biol
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
High
Report
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
9/25
02:04 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/17
05:31 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/9
02:07 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/3
08:04 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Ascendiant Capital Markets from $3.50 to $2.00. They now have a "buy" rating on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Ascendiant Capital Markets from $3.50 to $2.00. They now have a "buy" rating on the stock.
9/1
02:15 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
8/24
02:05 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.